Literature DB >> 10392174

[Efficacy of bilateral mastectomy in women with familial breast cancer].

B Gerber, K Friese.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10392174     DOI： 10.1007/BF02743585

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   4.033


× No keyword cloud information.
  6 in total

1.  BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.

Authors:  F J Couch; M L DeShano; M A Blackwood; K Calzone; J Stopfer; L Campeau; A Ganguly; T Rebbeck; B L Weber
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

2.  Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group.

Authors:  H F Vasen; N E Haites; D G Evans; C M Steel; P Møller; S Hodgson; D Eccles; P Morrison; D Stoppa Lyonet; J Chang-Claude; M Caligo
Journal:  Eur J Cancer       Date:  1998-11       Impact factor: 9.162

3.  Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.

Authors:  L C Hartmann; D J Schaid; J E Woods; T P Crotty; J L Myers; P G Arnold; P M Petty; T A Sellers; J L Johnson; S K McDonnell; M H Frost; R B Jenkins
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

4.  Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

Authors:  L C Verhoog; C T Brekelmans; C Seynaeve; L M van den Bosch; G Dahmen; A N van Geel; M M Tilanus-Linthorst; C C Bartels; A Wagner; A van den Ouweland; P Devilee; E J Meijers-Heijboer; J G Klijn
Journal:  Lancet       Date:  1998-01-31       Impact factor: 79.321

5.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Authors:  B Fisher; J P Costantino; D L Wickerham; C K Redmond; M Kavanah; W M Cronin; V Vogel; A Robidoux; N Dimitrov; J Atkins; M Daly; S Wieand; E Tan-Chiu; L Ford; N Wolmark
Journal:  J Natl Cancer Inst       Date:  1998-09-16       Impact factor: 13.506

6.  Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; D T Bishop; S A Narod; D E Goldgar
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.